Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1342
Peer-review started: May 11, 2023
First decision: May 31, 2023
Revised: June 11, 2023
Accepted: July 11, 2023
Article in press: July 11, 2023
Published online: August 15, 2023
Processing time: 91 Days and 13.2 Hours
Curcumin is a natural compound with a diketone structure, which can control the growth, metastasis, recurrence, neovascularization, invasion, and drug resistance of gastrointestinal tumors by inhibiting nuclear factor κB, overexpression of tumor cells, vascular endothelial growth factor, etc. However, due to the low bioavailability of curcumin formulation, it did not fully exert its pharmacological effects, and its application and development in the treatment of various malignant tumors are still limited. This review summarizes the research on drug delivery systems of curcumin combating digestive tract tumors in order to further reduce the toxic side effects of curcumin-containing drugs and fully exert their pharmacological activities, and improve their bioavailability and clinical value.
Core Tip: Curcumin can control the growth, metastasis, recurrence, neovascularization, invasion, and drug resistance of gastrointestinal tumors by inhibiting nuclear factor κB, overexpression of tumor cells, and vascular endothelial growth factor. It is important to clarify the application value of curcumin by different drug delivery systems to optimize the treatment of gastrointestinal tumors.
- Citation: Wu X, Yang Y. Research progress on drug delivery systems for curcumin in the treatment of gastrointestinal tumors. World J Gastrointest Oncol 2023; 15(8): 1342-1348
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1342.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1342
As the detection rate of advanced gastrointestinal tumors continues to rise, combination chemotherapy regimens, such as paclitaxel, capecitabine, and cisplatin, have become necessary to prolong patient survival[1,2]. However, many chemotherapy drugs have poor tumor selectivity and often have severe toxic side effects, which can damage the immune system's defense and regulatory functions and even make patients unable to tolerate subsequent treatments or develop drug resistance[3,4]. Moreover, the cost of chemotherapy combined with molecular targeted therapy is high, and patients have a low acceptance rate, making it unsuitable for widespread clinical use[5]. Compared with conventional chemo
Drug delivery system | Structure | Advantage | Disadvantage | Common types |
Polymer | Shell-core structure | Hydrophobic, high and precise drug concentration with low side effects | Poor water solubility | Bioadhesive micelles, active targeting micelles, etc. |
Liposome | Lipid bilayer microvesicle carriers | Diversity, targeting, lymphatic targeting, liver protection, etc. | High cost | Unilamellar liposomes, multilamellar liposomes, liposome gel, etc. |
Microsphere | Shell-core structure | Covering bad odors, avoiding incompatible combinations, high stability and safety | Relatively short duration and relatively large drug dosage | Conventional injection microspheres, occlusive microspheres, magnetic microspheres, etc. |
Nanoparticle (NPs) | Shell-core structure | Amphiphilic, controllable loading effect, long half-life, etc. | Low solubility of inorganic NPs | Lipophilic NPs, nanocapsules, nanospheres, and inorganic NPs, etc. |
Nanogel | Intramolecular cross-linked polymer | Anti-fouling, antibacterial, targeting, small size, easily penetrating cells, etc. | No obvious disadvantage | pH-responsive hydrogels, hyaluronic acid hydrogels, copolymer hydrogels |
Cyclodextrin | Bimolecular complex | High water solubility, low toxicity, high stability | No obvious disadvantage | α-cyclodextrin, β-cyclodextrin, partially methylated-β-cyclodextrin, etc. |
Micelles polymer micelles are a thermodynamically stable colloidal solution with a shell-core structure. The core can carry hydrophobic drugs and effectively reduce the degradation loss of drugs, enhance the drug permeability and retention, and thus increase the concentration of drugs in the target site or accumulate the drugs in specific areas, thereby strengthening their killing effect on tumor cells and significantly reducing the toxic side effects on normal cells and tissues[10,11]. Compared with traditional drug delivery systems, curcumin micelles can not only improve the uptake rate of drugs by tumor cells but also select appropriate micelles based on the specific conditions and related symptoms of tumor patients, such as bioadhesive micelles, active targeting micelles, pH-sensitive micelles, and reversal of multidrug-resistant micelles[12]. In immunotherapy of osteosarcoma, Jin et al[13] found that dichloroacetic acid mitochondrial-targeted polymer micelles could induce cell apoptosis by initiating the mitochondrial oxidative stress response, enhancing immunity, and inhibiting the tumor microenvironment. In addition, by designing the hydrophobic core of polymer micelles and the hydrophobic membrane of the vesicles, the shell-core structure becomes a photocatalyst, which can effectively avoid the attack of photodynamic oxygen on enzymatic substances, keep the enzyme in an active state, and thus enhance the biocompatibility and activity of the delivery system[14]. It should be noted that comprehensive tests on encapsulation efficiency, particle size, drug loading, and drug release rate within 48 h are required to prepare curcumin polymer micelles to the fullest extent possible to overcome its poor water solubility and maximize its anti-tumor effects.
Liposomes are lipid bilayer microvesicle carriers that can encapsulate multiple drugs and have good targeting and lymphatic directionality. Compared with ordinary carriers, they can not only delay renal metabolism, reduce drug toxicity but also serve as passive targeted drugs for the reticuloendothelial system, thus protecting the liver and improving drug efficacy[15]. In a mouse experiment, Li et al[16] compared several different curcumin drug delivery systems and found that mice given curcumin liposomes had greater improvements in hepatic steatosis than control group mice or mice given curcumin suspensions, and smaller abdominal adipocytes. In the study of digestive tract tumors, curcumin analogs, unlike non-steroidal anti-inflammatory drugs, have important value in regulating the cancer gene pathway, and cause fewer adverse reactions such as mucosal bleeding and gastrointestinal ulcers[17]. When curcumin acts on gastric or colorectal cancer, it can regulate the cell's anti-inflammatory, anti-cell apoptosis and antioxidant mechanisms through signal pathways such as DNA methylation, nuclear factor-erythroid 2-related factor 2, and histone modification, thus regulating the transcription of factors, such as heme oxygenase-1, Bcl-2, Bcl-xL, delaying tumor progression, and achieving multi-organ protection[18,19].
Microspheres, also known as microcapsules, are miniature spherical capsules made of polymeric materials that encapsulate or adsorb solid or liquid drugs. Their outer shell can mask the unpleasant odor of drugs, prevent contraindications in complex formulations, and reduce the stimulatory effects of chemotherapy drugs on the gastrointestinal mucosa[20]. The most commonly used microencapsulation method in clinical practice is to develop sustained-release and targeted drugs to control disease progression or symptoms. Some microspheres can also embed live cells and biologically active blood substances to prevent them from denaturing or becoming ineffective[21]. Researchers extracted proteins from lotus seeds and used them to encapsulate curcumin[22]. They found that at a concentration of 50mg/mL, the encapsulation rate of curcumin was 86.32%. After digestion in the gastrointestinal tract, the cumulative release rate of curcumin-LSP was 64.3%, while that of curcumin-LSP-pectin particles was 72.4%. Moreover, the dissolution rate of curcumin-LSP-pectin particles was relatively higher. Thus, microencapsulated compounds have a higher application value.
Nanoparticles (NPs) can penetrate into membrane cells, spread along nerve synapses and lymphatic vessels, and selectively accumulate in different cells and some cell structures[23]. According to their different shell-core structures and materials, NPs are divided into multiple drug delivery systems, such as lipophilic NPs, nanocapsules, nanospheres, and inorganic NPs. Their carriers can be hydrophobic or hydrophilic compounds, as well as small molecules, biomacromolecules, proteins, and vaccines[24]. Moreover, by adjusting the composition, stability, reactivity, and surface charge of NPs and carriers, the loading effect and release kinetics of drugs can be precisely controlled[25]. Lushchak et al[26] pointed out that nanoparticles carrying various plant bioactive compounds had a longer half-life than traditional formulations and could improve the permeability of epithelial cells and delayed cellular aging. Nabila et al[27] used nanolipid technology to prepare nano-curcumin and compared it with curcumin solution, proving that nano-curcumin had greater antiviral potential. It is worth noting that inorganic NPs synthesized from materials, such as gold, iron oxide, and silicon dioxide, have unique value in diagnosis, arterial imaging, photothermal therapy, and sonodynamic therapy. However, due to their toxicity and low solubility, the clinical application of such NPs still has certain limitations[28]. Dutta et al[29] coated the anionic surfactant sodium dodecyl sulfate (SDS) on the surface of hydrophobic Fe3O4 (oleic acid modified) nanoparticles to prepare a surface-active agent-stabilized, highly water-dispersible Fe3O4 magnetic nanocarrier (SMNC) capable of simultaneously carrying hydrophobic and hydrophilic anticancer drugs. Doxorubicin is adsorbed onto the surface of the nanocarrier by electrostatic interactions, while curcumin is encapsulated in the hydrophobic intermediate layer between oleic acid and SDS. The drug carrier has high drug loading capacity, good sustained release performance, and good cellular uptake ability. In addition, the drug carrier exhibits excellent heating ability under an alternating magnetic field and can be used as an effective heat source for hyperthermia.
Nanogel is a type of intramolecular cross-linked polymer with a particle size generally within 1000 nm. It has an internal network structure and can be dispersed into nanoscale hydrogel particles in aqueous solutions[30]. It can also be used as anti-fouling and antibacterial surface coatings, reducing the adhesion of bacteria and viruses on medical materials. The pH in the normal physiological environment of the body differs significantly from that outside the tumor cells, resulting in a significant redox potential difference between the inside and outside of the cells. However, monodispersed nanoscale hydrogels can respond specifically and accurately to the pH and redox potential differences between tumor tissues and normal tissues, creating conditions for targeted delivery of drugs to cancer sites[31,32]. Chemotherapy combined with immunotherapy is currently a popular method for treating mid-to-late-stage tumors. Its main goal is to promote the death of immunogenic cells, activate the powerful function of the immune system, and achieve the purpose of inhibiting tumor growth and improving the immunosuppressive tumor microenvironment[33]. Ma et al[34] prepared mannitol nanogels based on polyβ-amino esters to treat breast cancer and found that it could overcome the limitations of immunotherapy. Therefore, nanogels can achieve specific co-delivery of tumor drugs.
Cyclodextrin is a cyclical oligosaccharide derived from starch. By appropriately modifying it chemically, amorphous or partially crystalline derivatives such as α-cyclodextrin, β-cyclodextrin, partially methylated-β-cyclodextrin, etc., can be formed, which can significantly improve its water solubility and greatly reduce its gastrointestinal toxicity[35]. Among them, the inclusion complex of hydroxypropyl-β-cyclodextrin and curcumin has not only a high inclusion rate and high solubility, but also a 2.8-fold increase in bioavailability compared to ordinary curcumin preparations, and the concentration in the brain increases by 38.7-fold, showing a significant antiepileptic effect[36]. In addition, Chen et al[37] showed that curcumin-cyclodextrin complex has a protective effect on H2O2-induced LO2 cell damage, can effectively inhibit the overexpression of caspase-3, and alleviate liver, kidney, brain and skeletal muscle damage. This indicates that preparing curcumin-cyclodextrin inclusion complexes according to the chemical and biological properties of drugs can alleviate liver, kidney, and nerve toxicities during anti-tumor chemotherapy. In the study of curcumin solubility, the antioxidant activity of curcumin inclusion complexes formed with β-cyclodextrin and polyvinylpyrrolidone (PVP) was (96.02 ± 2.46)%, while the antioxidant activity of pure curcumin was only (58.02 ± 2.21)%. This shows that designing curcumin-β-cyclodextrin complexes with PVP can further improve the in vivo activity of curcumin[38].
Developing drug delivery systems for curcumin, such as micelles, complexes, solvent-free pH-driven capsules, and gels, to fully enhance its effectiveness and develop therapeutic or functional products, has become one of the choices to promote overall health and increase tumor remission rates[39]. However, despite the current clinical research in gastrointestinal tumors, the efficacy of curcumin remains uncertain (Table 2)[40-43]. In addition to the studies shown in the table, Hipólito-Reis et al[44] demonstrated that by reducing the release and production of inflammatory mediators using curcumin, curcumin can lower cell proliferation, blood vessel growth, invasion, and adhesion, or regulate cell apoptosis, lipid metabolism mechanisms, etc., which can effectively improve the occurrence and development of endometriosis and achieve long-term control or clinical cure[45,46]. Meanwhile, the invasion and proliferation of tumor cells can also promote the secretion of multifunctional chemokines such as TNF-α, IL-6, IL-8, IL-10, decrease pain thresholds, and promote inflammatory exudation and necrosis of local lesions. Therefore, Nanavati et al[47] believe that supplementing 90-5000 mg curcumin daily can effectively improve subjective pain perception and increase the body's antioxidant capacity.
Cancer type | Study category | No. | Dosage regimen | Results |
Colorectal cancer[37] | Phase II, randomized double-blind study | 22 | Capecitabine 825 mg/m2, Bid; curcumin 4 g, Bid | Curcumin does not increase the remission rate of patients |
Esophageal cancer[38] | Controlled trial | 1 | Group A: 20 µg/mL curcumin-containing culture; Group B: 2 µg/mL Vincristine-containing culture; Combined group: 20 µg/mL curcumin+2 µg/mL vincristine-containing culture | Curcumin reverses multidrug resistance of esophageal cancer cells |
Metastatic colorectal cancer[39] | Phase IIa, randomized controlled trial | 28 | Control group: FOLFOX1; Research Group: FOLFOX + curcumin 2 g/d | Curcumin plus FOLFOX regimen significantly improves chemotherapy tolerance and safety |
Advanced gastric cancer[40] | Randomized controlled trial | 56 | Control group: FOLFOX; Research Group: FOLFOX + curcumin 25 µmol/L, 1/d | Curcumin plus FOLFOX regimen significantly improves clinical remission rate and reduces toxic side effects |
The anti-tumor effect of curcumin is closely related to multiple mechanisms. When it acts on the signaling pathway of various cytokines, it can exert different regulatory functions, thereby regulating immunity and inflammation, protecting cells, and inhibiting tumor growth. For specific cancer patients, the development of curcumin delivery systems can significantly enhance the targeting and long-circulating effects of the drugs. Polymer micelles, liposomes, and microspheres have considerable advantages, but this article did not provide a detailed analysis of their drawbacks, and it is not entirely clear how to choose the material and type of drug delivery systems. Therefore, in future research, the application value of curcumin by different drug delivery systems needs to be further analyzed to optimize the treatment of gastrointestinal tumors.
Provenance and peer review: Unsolicited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Oncology
Country/Territory of origin: China
Peer-review report’s scientific quality classification
Grade A (Excellent): 0
Grade B (Very good): B, B
Grade C (Good): 0
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Iruarrizaga-Lejarreta M, Spain; Sledzinski T, Poland S-Editor: Yan JP L-Editor: A P-Editor: Yan JP
1. | Santa Chalarca CF, Dalal RJ, Chapa A, Hanson MG, Reineke TM. Cation Bulk and pK(a) Modulate Diblock Polymer Micelle Binding to pDNA. ACS Macro Lett. 2022;11:588-594. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis (0)] |
2. | Tulsi R, Ul Haque MM, Hanif FM, Devi A, Mubarak M, Hassan Luck N. Metastasis of Duodenal Adenocarcinoma to the Urinary Bladder Presenting as Hematuria. J Transl Int Med. 2021;9:143-145. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
3. | Chao YH, Gao MM, Nie AZ, Sun BJ, Du SZ, Nie HJ. Development of disulfide bond mediated tumor microenvironment responsive drug delivery system. Zhongnan Yaoxue. 2021;7:1364-1369. [Cited in This Article: ] |
4. | Liu P, Zhu H, Zhang X, Feng A, Zhu X, Sun Y. Predicting Survival for Hepatic Arterial Infusion Chemotherapy of Unresectable Colorectal Liver Metastases: Radiomics Analysis of Pretreatment Computed Tomography. J Transl Int Med. 2022;10:56-64. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 15] [Reference Citation Analysis (0)] |
5. | Angeline N, Suhito IR, Kim CH, Hong GP, Park CG, Bhang SH, Luo Z, Kim TH. A fibronectin-coated gold nanostructure composite for electrochemical detection of effects of curcumin-carrying nanoliposomes on human stomach cancer cells. Analyst. 2020;145:675-684. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
6. | Calibasi-Kocal G, Pakdemirli A, Bayrak S, Ozupek NM, Sever T, Basbinar Y, Ellidokuz H, Yigitbasi T. Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. J BUON. 2019;24:1482-1487. [PubMed] [DOI] [Cited in This Article: ] |
7. | Chen ZR, Fan B. Research progress on the mechanism and local delivery system of curcumin in the treatment of psoriasis. Shijie Linchuang Yaowu. 2022;43:1207-1213. [Cited in This Article: ] |
8. | Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59:89-101. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 186] [Cited by in F6Publishing: 247] [Article Influence: 35.3] [Reference Citation Analysis (0)] |
9. | Zhang XL, Li YP, Lv SW, Wang YH, Li YJ. Research Progress of Curcumin Nanocarriers and Their Applications. Dangdai Huagong. 2021;11:2685-2688. [Cited in This Article: ] |
10. | Liu YR, Wu MF, Sun YQ. Preparation and Evaluation of Curcumin-loaded Polymeric Micelles Based on Copolymer Cholesterol-hyaluronic Acid. Zhongguo Yaoxue Zazhi. 2020;51:613-619. [Cited in This Article: ] |
11. | Yusuf H, Wijiani N, Rahmawati RA, Primaharinastiti R, Rijal MAS, Isadiartuti D. Analytical method for the determination of curcumin entrapped in polymeric micellar powder using HPLC. J Basic Clin Physiol Pharmacol. 2021;32:867-873. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
12. | Mizumoto A, Ohashi S, Kamada M, Saito T, Nakai Y, Baba K, Hirohashi K, Mitani Y, Kikuchi O, Matsubara J, Yamada A, Takahashi T, Lee H, Okuno Y, Kanai M, Muto M. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma. J Gastroenterol. 2019;54:687-698. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis (0)] |
13. | Jin J, Yuan P, Yu W, Lin J, Xu A, Xu X, Lou J, Yu T, Qian C, Liu B, Song J, Li L, Piao Y, Xie T, Shen Y, Tao H, Tang J. Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy. ACS Nano. 2022;16:10327-10340. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 54] [Article Influence: 27.0] [Reference Citation Analysis (0)] |
14. | Zhang N, Trépout S, Chen H, Li MH. AIE Polymer Micelle/Vesicle Photocatalysts Combined with Native Enzymes for Aerobic Photobiocatalysis. J Am Chem Soc. 2023;145:288-299. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 9] [Reference Citation Analysis (0)] |
15. | Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr. 2020;60:887-939. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 121] [Cited by in F6Publishing: 234] [Article Influence: 46.8] [Reference Citation Analysis (0)] |
16. | Li H, Liu ZH, Li H, Qing DX. Effect of curcumin liposomes on lipid-lowering and hepatoprotective effects of hyperlipidemia-induced nonalcoholic fatty liver disease mice]. Chin Med. 2020;15:1053-1057. [Cited in This Article: ] |
17. | Morshedi K, Borran S, Ebrahimi MS, Masoud Khooy MJ, Seyedi ZS, Amiri A, Abbasi-Kolli M, Fallah M, Khan H, Sahebkar A, Mirzaei H. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytother Res. 2021;35:4834-4897. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis (0)] |
18. | Zhang W, Cui N, Ye J, Yang B, Sun Y, Kuang H. Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism. Chin Herb Med. 2022;14:244-253. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Reference Citation Analysis (1)] |
19. | Wu R, Wang L, Yin R, Hudlikar R, Li S, Kuo HD, Peter R, Sargsyan D, Guo Y, Liu X, Kong AN. Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer. Mol Carcinog. 2020;59:227-236. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis (0)] |
20. | Joshi P, Joshi S, Semwal D, Bisht A, Paliwal S, Dwivedi J, Sharma S. Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity. Mini Rev Med Chem. 2021;21:2420-2457. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis (0)] |
21. | Patel SS, Pushpadass HA, Franklin MEE, Battula SN, Vellingiri P. Microencapsulation of curcumin by spray drying: Characterization and fortification of milk. J Food Sci Technol. 2022;59:1326-1340. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis (0)] |
22. | Su Y, Chen Y, Zhang L, Adhikari B, Xu B, Li J, Zheng T. Synthesis and characterization of lotus seed protein-based curcumin microcapsules with enhanced solubility, stability, and sustained release. J Sci Food Agric. 2022;102:2220-2231. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis (0)] |
23. | Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2020;34:896-903. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 28] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis (0)] |
24. | Wu Y, Liu H, Li Z, Huang D, Nong L, Ning Z, Hu Z, Xu C, Yan JK. Pectin-decorated selenium nanoparticles as a nanocarrier of curcumin to achieve enhanced physicochemical and biological properties. IET Nanobiotechnol. 2019;13:880-886. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis (0)] |
25. | Li YQ, Li XJ. Basic and clinical research progress in antitumor effect of curcumin. Zhongguo Yaolixue Yu Dulixue Zazhi. 2020;34:321-335. [Cited in This Article: ] |
26. | Lushchak O, Strilbytska O, Koliada A, Zayachkivska A, Burdyliuk N, Yurkevych I, Storey KB, Vaiserman A. Nanodelivery of phytobioactive compounds for treating aging-associated disorders. Geroscience. 2020;42:117-139. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis (0)] |
27. | Nabila N, Suada NK, Denis D, Yohan B, Adi AC, Veterini AS, Anindya AL, Sasmono RT, Rachmawati H. Antiviral Action of Curcumin Encapsulated in Nanoemulsion against Four Serotypes of Dengue Virus. Pharm Nanotechnol. 2020;8:54-62. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis (0)] |
28. | Dai T, He W, Yao C, Ma X, Ren W, Mai Y, Wu A. Applications of inorganic nanoparticles in the diagnosis and therapy of atherosclerosis. Biomater Sci. 2020;8:3784-3799. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 30] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis (0)] |
29. | Dutta B, Shetake NG, Barick BK, Barick KC, Pandey BN, Priyadarsini KI, Hassan PA. pH sensitive surfactant-stabilized Fe(3)O(4) magnetic nanocarriers for dual drug delivery. Colloids Surf B Biointerfaces. 2018;162:163-171. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis (0)] |
30. | Guo XY, Wang Z, Xia MP. [Research progress of medical nano gel surface coating with antifouling/antibacterial function]. Mater Introduct. 2022;36:446-451. [Cited in This Article: ] |
31. | Maleki Dizaj S, Alipour M, Dalir Abdolahinia E, Ahmadian E, Eftekhari A, Forouhandeh H, Rahbar Saadat Y, Sharifi S, Zununi Vahed S. Curcumin nanoformulations: Beneficial nanomedicine against cancer. Phytother Res. 2022;36:1156-1181. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 10] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis (0)] |
32. | Zakaria H, El Kurdi R, Patra D. A Novel Study on the Self-Assembly Behavior of Poly(lactic-co-glycolic acid) Polymer Probed by Curcumin Fluorescence. ACS Omega. 2022;7:9551-9558. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
33. | Lu Y, Jia D, Ma X, Liang M, Hou S, Qiu W, Gao Y, Xue P, Kang Y, Xu Z. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy. ACS Appl Mater Interfaces. 2021;13:8940-8951. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis (0)] |
34. | Ma X, Yang S, Zhang T, Wang S, Yang Q, Xiao Y, Shi X, Xue P, Kang Y, Liu G, Sun ZJ, Xu Z. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy. Acta Pharm Sin B. 2022;12:451-466. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 21] [Cited by in F6Publishing: 67] [Article Influence: 33.5] [Reference Citation Analysis (0)] |
35. | Isadiartuti D, Rosita N, Ekowati J, Syahrani A, Ariyani T, Rifqi MA. The thermodynamic study of p-methoxycinnamic acid inclusion complex formation, using β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J Basic Clin Physiol Pharmacol. 2021;32:663-667. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 1] [Reference Citation Analysis (0)] |
36. | Zeng Y, Lv Y, Hu M, Guo F, Zhang C. Curcumin-loaded hydroxypropyl-β-cyclodextrin inclusion complex with enhanced dissolution and oral bioavailability for epilepsy treatment. Xenobiotica. 2022;52:718-728. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 5] [Reference Citation Analysis (0)] |
37. | Chen J, Li J, Fan T, Zhong S, Qin X, Li R, Gao J, Liang Y. Protective effects of curcumin/cyclodextrin polymer inclusion complex against hydrogen peroxide-induced LO2 cells damage. Food Sci Nutr. 2022;10:1649-1656. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Reference Citation Analysis (1)] |
38. | Jafar M, Khalid MS, Aldossari MFE, Amir M, Alshaer FI, Adrees FAA, Gilani SJ, Alshehri S, Hassan MZ, Imam SS. Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment. Drug Dev Ind Pharm. 2020;46:1524-1534. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
39. | Abd El-Hack ME, El-Saadony MT, Swelum AA, Arif M, Abo Ghanima MM, Shukry M, Noreldin A, Taha AE, El-Tarabily KA. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric. 2021;101:5747-5762. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 86] [Cited by in F6Publishing: 131] [Article Influence: 43.7] [Reference Citation Analysis (0)] |
40. | Gunther JR, Chadha AS, Guha S, Raju GS, Maru DM, Munsell MF, Jiang Y, Yang P, Felix E, Clemons M, Mathew GG, Singh PK, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Delclos ME, Crane CH, Das P, Krishnan S. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. J Gastrointest Oncol. 2022;13:2938-2950. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
41. | Wang WB, Zhang LX, Luo Q, Ren HY, Niu SR. Curcumin reverses the drug resistance of esophageal cancer Eca-109 /VCR cells. Zhongguo Linchuang Yaolixue Zazhi. 2021;37:136-139. [Cited in This Article: ] |
42. | Howells LM, Iwuji COO, Irving GRB, Barber S, Walter H, Sidat Z, Griffin-Teall N, Singh R, Foreman N, Patel SR, Morgan B, Steward WP, Gescher A, Thomas AL, Brown K. Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. J Nutr. 2019;149:1133-1139. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 78] [Cited by in F6Publishing: 139] [Article Influence: 27.8] [Reference Citation Analysis (0)] |
43. | Yang WL, Yang RP, Luo YS, Hu S, Liu Q. Clinical analysis of curcumin combined with FOLFOX regimen in the treatment of advanced gastric cancer. nner Mongolia Yike Daxue Xuebao. 2019;41:96-99. [Cited in This Article: ] |
44. | Hipólito-Reis M, Neto AC, Neves D. Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review. Phytother Res. 2022;36:2416-2433. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis (0)] |
45. | Ms SAB, Waldman PhD HS, Krings PhD BM, Lamberth PhD J, Smith PhD JW, McAllister PhD MJ. Effect of Curcumin Supplementation on Exercise-Induced Oxidative Stress, Inflammation, Muscle Damage, and Muscle Soreness. J Diet Suppl. 2020;17:401-414. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis (0)] |
46. | Wang Q, Zhang K, Weng W, Chen L, Wei C, Bao R, Adu-Frimpong M, Cao X, Yu Q, Shi F, Toreniyazov E, Ji H, Xu X, Yu J. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation. J Pharm Sci. 2022;111:2083-2092. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
47. | Nanavati K, Rutherfurd-Markwick K, Lee SJ, Bishop NC, Ali A. Effect of curcumin supplementation on exercise-induced muscle damage: a narrative review. Eur J Nutr. 2022;61:3835-3855. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis (0)] |